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Background: Around 33-50% who attend treatment for substance use disorder (SUD) 
and alcohol use disorder (AUD) have a history of trauma. Experiencing trauma can 
lead to psychological disorders, difficulties with emotional regulation and 
dissociation. SUD and AUD can be chronic, relapsing disorders and understanding 
what individual factors affect addiction has important implications for treatment.  
 
Objective: The systematic review was interested in whether alexithymia affects 
abstinence after relapse prevention treatment (both psychological and 
pharmacological). The review was also interested in whether alexithymia is a stable 
trait after relapse prevention treatment (both psychological and pharmacological) as 
measured by the Toronto Alexithymia Scale. The research study investigates the 
relationships between trauma, dissociation, alexithymia, emotional regulation and 
SUD, AUD and polysubstance use. There has been little research looking at the 
relationships between these variables and how they compare in different types of 
substance use. It was hypothesised that patients with poly-substance addiction will 
have higher incidents of trauma, dissociation, alexithymia and poorer emotional 
regulation when compared to alcohol and drug dependence alone. 
 
Methods: A systematic search of articles published between January 1989 - January 
2017 was carried out following the Cochrane (2008) guidelines. PSYCHInfo, Medline 
and Cinahl were the key databases searched.  Papers were quality assessed to identify 
strengths and weaknesses. The research study is a qualitative, cross-sectional design 
that involved ninety-one AUD, SUD and poly-substance use participants who were 
attending outpatient NHS addiction services. They were asked to complete 
questionnaires assessing trauma, dissociation, alexithymia and emotional regulation.  
Results: The systematic review found twelve articles that related to the review 
questions. The systematic review found alexithymia did not impact on abstinence and 
there was no difference between abstinence after treatment between low and high 
alexithymic groups. There were mixed results for whether alexithymia score changes 
after relapse prevention treatment. Overall, the results suggest that alexithymia is 
	 7	
relatively stable across SUD and AUD after relapse prevention treatment. The 
empirical study found that there is no difference between type of addiction and trauma, 
alexithymia and emotional regulation. People with polysubstance misuse reported 
significantly higher levels of dissociation than the other two groups. Multiple 
regression was conducted on the full data set and it was found that emotional 
regulation, alexithymia and dissociation were able to predict trauma in alcohol, drug 
and polysubstance users.  
 
Conclusions: The systematic review found that despite the assumption that people 
with alexithymia have higher rates of relapse and attrition this is not the case. 
Alexithymia has no impact on treatment outcome. The review also found that CBT 
was identified as an effective relapse prevention treatment for people with 
alexithymia. The research paper highlighted that the type of substance used by people 
who have experienced trauma may not be as important as previously thought. Also, 
understanding that poor emotional regulation, alexithymia and dissociation commonly 
co-occur with trauma so it may be important to screen for this when treating people 
with trauma who have co-morbid addictions.  
 















2.1 Stability of alexithymia and its impact on relapse prevention treatment in 




Word count: Abstract (including highlights): 255 





Objective: It is the aim of this paper to systematically review and provide a narrative 
synthesis on whether the presence of alexithymia in people with alcohol use disorder and 
substance use disorder affects relapse rates and attrition after psychosocial and 
pharmacological relapse prevention treatment Also, this review will look at stability in 
alexithymia in people with AUD and/or SUD after detoxification or psychosocial relapse 
prevention treatment. 
Method: A systematic search of Medline, PsycINFO and CINAHL published between 
1989 and January 2017 was undertaken to find relevant articles. The methodological 
quality of the articles was assessed using Downs and Black (1998) quality assessment 
tool. 
Results: Twelve studies of varying methodological quality were identified as being able 
to answer both questions. Alexithymia did not affect attrition and abstinence rates after 
psychosocial relapse prevention treatment. Alexithymia was found to have relative 
stability but no absolute stability in SUD and AUD after relapse prevention treatment.  
Discussion: A lack of relationship between alexithymia and attrition and abstinence in 
SUD and AUD was the consistent finding of the papers reviewed. The conclusions drawn 
from this review are tentative that alexithymia has no absolute stability but is a relatively 
stable trait in SUD and AUD. The conclusion drawn should be taken with caution due to 
varying follow up times, varying sample sizes between papers, varying methodological 
quality and that only one study looked at AUD.   
 
2.3 HIGHLIGHTS 
• Level of alexithymia is unrelated to attrition and abstinence in SUD and AUD  
• Alexithymia does not have absolute stability in AUD and SUD 
• Alexithymia has relative stability in SUD and AUD 
 





Alexithymia is considered a difficulty of affect regulation (Taylor, Bagby & Parker, 
1997). It was first broadly defined by Sifneos (1973) as having no words for emotions and 
has both emotional and cognitive components. The emotional component is characterized 
by deficits in identifying and describing emotion, and having problems differentiating 
between emotion and somatic experience. The cognitive aspect of alexithymia is having 
an impaired ability to fantasize, an externally oriented thinking style and a reduced ability 
to think introspectively. Alexithymia has been identified throughout the world in different 
ethnic, cultural and racial groups (Parker et al, 2005; Taylor, Parker & Bagby, 2003) and 
is prevalent in approximately 10% of the general population (Taylor, Bagby & Parker, 
1999).  
 
Alexithymia has been identified in a range of psychological problems such as depression 
(Kim et al., 2008; Honkalampi et al., 2000), anxiety (Cox, Swinson, Shulman & 
Bourdeau, 1995) schizophrenia and eating disorders (Cochrane, Brewerton, Wilson & 
Hodges, 1993). It has also been associated with increased suicidality (Hintikka et al., 
2004), heightened psychosomatic conditions (Lane, 2008) and even elevated mortality 
rates (Tolmunen et al., 2010). Prevalence of alexithymia in alcohol use disorders (AUD) 
ranges between 45-67% (Thorberg et al., 2009) which is considerably higher than the 
general population and other psychological problems (Saarijärvi, Salminen & Toikka, 
2006; Marchesi, 2015). In alcohol use disorders and substance use disorders (SUD) 
alexithymia is associated with further risk factors such as higher levels of negative 
emotion and more troubling somatic symptoms such pain and fatigue (de Sousa et al., 
2010). 
 
2.4.2 Development of alexithymia in Addiction 
Demers et al. (2015) have proposed that disruption in normal neurodevelopmental 
processes caused by childhood trauma and neglect results in the development of 
alexithymia. Other studies have also found that psychiatric outpatients with PTSD who 
reported abuse and neglect in childhood were more likely to have alexithymia. This was 
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even when compared to other types of traumatic events (Zlotnick, Mattia & Zimmerman, 
2001; Spitzer et al., 2007).  This has also been replicated in patients with severe depression 
who have experienced childhood trauma (Paivio & McCulloch, 2004). Childhood abuse 
has been shown to predict problems with emotional awareness, emotional regulation and 
difficulties in expression of feelings (Taylor, Parker & Bagby, 1997). Early trauma can 
impact attachment relationships especially when the traumatic experience is perpetrated 
by the main caregiver (Briere, 1992). Children who develop insecure attachment 
relationships with their caregivers have difficulties with cognitive and emotional 
processing (Knox, 2003). Thorberg et al. (2011) examined attachment relationships and 
alexithymia in an AUD population to understand the role attachment and early trauma has 
in this population. They found that alexithymic people with AUD reported higher levels 
of childhood trauma and higher levels of anxious attachment that non alexithymic AUD 
participants.  
 
Substance and alcohol addiction are chronic and relapsing conditions and a large 
proportion of individuals who have been treated for addiction tend to relapse shortly after 
treatment (Walton, Blow, Bingham & Chermack, 2003; Xie, McHugo, Fox & Drake, 
2005). People with AUD and alexithymia report a stronger desire to drink, tend to drink 
more often and in larger quantities than a similar population without alexithymia 
(Thorberg et al., 2011; Lyyers, Onuona, Thorberg & Samios, 2012). It has been proposed 
that having alexithymia could be a risk factor in developing AUD (Thorberg et al., 2011). 
It may be that people use substances to regulate their emotions and block negative feelings 
(Somer, 2003). Similar findings were found for people with SUD and concurrent high 
levels of alexithymia (e.g. Hamidi et al., 2010; Carton, et al., 2010.). It may be that one 
of the mechanisms in the development of alexithymia is the experience of early trauma 
which results in difficulties with emotional processing (Taylor, Bagby & Parker, 1997).     
 
2.4.3 Measurement of Alexithymia  
The Toronto Alexithymia Scale (the TAS-20) is the most widely used and studied measure 
of alexithymia (Bagby, Parker & Taylor, 1994; Cleland et al., 2005). The TAS-20 has 
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three subscales measuring difficulties in identifying feelings (DIF), difficulty describing 
feelings (DDF) and externally orientated thinking (EOT) (Taylor, Parker & Bagby, 2003). 
Marchesi, Ossola, Tonna & Panfilis (2014) investigated what the TAS-20 measured when 
assessing alexithymia and looked at a range of psychological disorders including SUD. 
They concluded that scores on the TAS-20 may be inflated if the patient has high levels 
of distress and that the TAS-20 is a measure of distress rather than alexithymia. Cleland 
et al. (2005) looked at the suitability of the TAS-20 as a measure of alexithymia in SUD 
and AUD. They found that the majority of the questions accurately measured alexithymia 
in this population group. Therefore, there are some mixed findings on how alexithymia is 
measured in people with alcohol and drug addiction.  
2.4.4 Stability of Alexithymia  
Parker, Taylor & Bagby (2001) have proposed that there may be two different ways of 
conceptualising alexithymia. The first is that alexithymia is a trait, an enduring personality 
characteristic that does not alter over time. The second is that alexithymia is a state which 
is evoked during times of stress. This is often described in the literature as absolute and 
relative stability. Absolute stability is the extent to which scores on a measure of 
alexithymia change over time. In contrast, relative stability is the level of which relative 
differences between individuals remain the same over time. Luminet, Bagby & Parker 
(2001) examined the absolute and relative stability of alexithymia in people with 
depression. They found that alexithymia scores as measured by the TAS-20 changed 
significantly in the three months from baseline to follow-up which suggests that 
alexithymia does not have absolute stability in this group. However, scores at baseline 
correlated with scores at follow-up suggesting that alexithymia has relative stability. From 
this study, they concluded that alexithymia is a stable personality trait and not a state 
dependent occurrence. There has been uncertainty in the addiction literature as to whether 
alexithymia is a trait or a state. For example, the high prevalence rates (45-67% found by 
Thorberg et al., 2009) have also been observed in patients that are abstinent (Taylor, 
Graeme, Bagby & Parker, 1997). Therefore, having an understanding whether 
alexithymia is state dependent and will reduce or is a stable personality characteristic may 
be an important consideration when treating addiction. 
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2.4.5 Relapse Prevention Treatment in SUD and AUD 
It has been found that alexithymia is linked with severity of psychological distress and 
treatment outcome (Samur et al., 2013; Ogrodniczuk, Piper & Joyce, 2011). Ogrodniczuk, 
Piper & Joyce (2011) conducted a review on how alexithymia affects the process and 
outcome of psychological therapy. They found that people with alexithymia have poorer 
outcomes and higher attrition with psychodynamic psychotherapy and therapists had a 
more negative reaction to these patients. This may be in part due to the difficulty people 
with alexithymia have with describing their emotions. Typical treatment of alcohol and 
substance misuse disorders involves the medical management of detoxification and 
psychosocial treatments for relapse prevention. NICE guidelines (2007; 2011) 
recommend that the most effective psychosocial treatments for maintaining abstinence 
are individual or group Cognitive Behavioural Therapy (CBT), motivational interviewing 
(MI), community reinforcement and mutual self-help groups including Alcoholics 
Anonymous (AA) or Narcotics Anonymous (NA).  
 
2.4.6 Purpose of Review  
Thorberg et al. (2009) conducted a review into alexithymia and alcohol addiction. They 
found that alexithymia and alcohol addiction were positively associated with dependence 
severity, level of alcohol consumption and poor interpersonal relationships. Thorberg et 
al.’s (2009) critical review in this area was a valuable summary of research on alexithymia 
and alcohol addiction. However, this was not a systematic review and the quality of 
evidence reviewed was not assessed. Also, to date there has been no review on the impact 
of alexithymia on attrition and relapse or the stability of alexithymia following AUD and 
SUD treatment. Ogrodniczuk, Piper and Joyce (2011) found that having alexithymia had 
a negative effect on therapeutic outcome following psychological therapy and that a 
poorer therapeutic alliance was developed. Recent research has conceptualised 
alexithymia as a consequence of early life trauma and disrupted attachment. This review 
will add to understanding about how emotional regulation problems such as alexithymia 
impact on treatment outcomes in a difficult to treat population. Therefore, reviewing 
whether having alexithymia increases the rates of attrition and relapse in AUD and SUD 
populations has clinical utility. Also, reviewing the available literature to determine 
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whether alexithymia is a state or a trait adds to understanding about whether alexithymia 
is a stable personality construct in people with alcohol and drug addictions.  
 
It is the aim to systematically review and provide a narrative synthesis of whether the 
presence of alexithymia in people with alcohol use disorder and substance use disorder 
affects relapse rates and attrition after psychosocial and pharmacological relapse 
prevention treatment Also, this review will look at stability in alexithymia in people with 
AUD and/or SUD after detoxification or psychosocial relapse prevention treatment in 
order to investigate whether alexithymia is an absolute or relatively stable construct. 
 
2.5 METHOD  
2.5.1 Protocol and Registration 
This systematic review was registered on PROSPERO www.crd.york.ac.uk . Registration 
number: 42017054574. 
 
2.5.2 Literature Search Strategy  
A literature search was carried out using three electronic databases: Medline [1989-
January 2017], PsycINFO [1989- January 2017], CINAHL [1989 - January 2017]. The 
search was started at 1989 as this was the earliest starting point for the data bases. The 
search also included verifying that no other similar reviews had been carried out. The 
search terms used related to a population that had an ‘alcohol use disorder’ (AUD) or 
“substance use disorder” (SUD) and were combined using ‘AND’ with terms linked to 
‘alexithymia’. Each key word inclusion was checked for each database to ensure all the 
areas of focus were included. This meant that key words used for the search were 
“alexithymia” and “alcohol use”, “alcohol use disorder”, “alcoholism”, “substance use 
disorder”, “addiction”, “relapse” or “alcohol”.  Searches were confined to the title, 
abstract and keywords. Searches were also carried out in reference lists of all articles that 
were eligible, as well as a search for citations of each of these articles. This enabled 
articles that may have been published earlier than 1989 to be searched. 
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2.5.3 Eligibility Criteria  
Studies were included if: 1) articles were published in English and in a peer reviewed 
journal; 2) papers included individuals with AUD or SUD who were over the age of 16; 
3) the primary research aim was to evaluate change in alexithymia levels after relapse 
prevention treatment (either pharmacological or psychosocial) or that investigated the 
effect of alexithymia on abstinence after relapse prevention treatment (either 
pharmacological or psychosocial). Group or individual CBT, MI, community 
reinforcement or mutual support groups were considered to be appropriate psychosocial 
relapse prevention treatments as these are the recommended treatments with the most 
robust evidence based for efficacy (NICE, 2007; 2011).  
 
2.5.4 Exclusion Criteria  
Studies were excluded if: (1) they did not use quantitative data, using only descriptive 
reports or having a theoretical focus (2) did not use a valid measure of alexithymia (3) 
they were case studies.  
2.5.5 Selection of Articles  
The literature search process is detailed in Figure 1. The initial search, using the 
previously mentioned search strategy, produced 483 articles. After duplicates were 
removed this reduced to 221 articles. The titles and abstracts of these articles were read 
to determine if they were appropriate for inclusion. This excluded a further 184 papers, 
leaving 37 papers to review in more detail. A further 27 papers did not meet inclusion 
criteria so the remaining 10 articles were included in this review. The references of these 
10 papers were also searched for possible articles that were not included in the original 
database search. From this a further 2 were identified as papers for inclusion; therefore, 
12 papers were included in this systematic review. This is summarized in Figure 1. The 
twelve papers that met inclusion criteria were reviewed in detail. Summary information 
from each article was identified and presented in Table 1. This included sample numbers 
and characteristics, relapse prevention intervention (duration, type and follow-up), 
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alexithymia assessment, results and outcome. It should be noted that two papers used data 
from the same study. 
2.5.6 Assessment of Quality of Included Studies  
The quality of the included studies was assessed to determine how much weight should 
be given to the results of each paper. The quality criteria used to assess the chosen studies 
was a shortened version of Downs and Black (1998) quality assessment tool. The reason 
for amending the tool was to remove questions that were not relevant to the types of 
studies that were reviewed in order to not unfairly disadvantage them (e.g. questions more 
suited to RCTs). Downs and Black (1998) has been found to have good test-retest 
reliability (r=0.88) and good inter-rater reliability (r=0.75). The tool has been 
recommended as a reliable tool to assess methodological quality (Deeks at al., 2003). 
The reviewer rated each paper against the Downs and Black criteria. In order to check the 
validity of the reviewer’s scoring decisions SIGN (2008) recommends that the quality 
assessment should also be undertaken by a second researcher to ensure consistency. A 
doctoral level student was asked to review 50% of the papers. There was good agreement 
between the two raters’ judgements (89%). Discussions took place to identify the 












Figure 1: Flow chart of included articles based on Prisma guidelines (Moher et al., 





























































2.6 RESULTS  
2.6.1 Description of Included Studies  
Overall, there were 1293 participants with SUD or AUD included in this review over 
the twelve studies. De Haan et al. (2012a) and De Haan et al. (2012b) used the same 
group of participants for their research so their participant numbers have only been 
included once in the overall total. Table 1 has a summary of the papers reviewed.  
All studies used the TAS-20 (Bagby, Taylor & Parker, 1994). One study Loas et al. 
(2007) used the Beth-Israel Questionnaire (BIQ; Sifneos, 1973) to initially screen 
participants into high and low alexithymic groups.  
All studies used the DSM-IV (1994) as their criteria for making a diagnosis of alcohol 
or substance use disorder. Some studies identified that this diagnosis had been made 
by the researchers by clinical interview or it was stated that meeting diagnostic criteria 
was part of the inclusion criteria for the study. 
2.6.2 Quality of included studies  
The quality ratings for the twelve studies as assessed by twenty-one quality criteria 
questions from Downs and Black (1998) are presented below in Table 2. It is important 
to note that this is not a comparative measure but an indication of the studies’ 
methodological strengths and weaknesses. From this Stasiewicz et al. (2012), De Haan 
et al. (2014) and De Haan et al. (2012a) had the strongest methodological studies. The 
other studies included had variable methodological strength. It should be noted that 
none of the studies reported power calculations, however, the majority of the studies 
had large sample sizes.  
2.6.3 Does alexithymia influence treatment outcomes after relapse prevention 
treatment? 
Psychosocial Relapse Prevention Interventions 
Eight of the studies included in this review looked at the influence of alexithymia on 
relapse after treatment. Some of these studies also looked at whether alexithymia 
affected attrition rate. Rosenblum et al. (2005) looked at participants with SUD and 
separated them into two relapse prevention treatment groups of group based CBT 
where participants were taught relapse prevention strategies. This was a manualized 
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approach to ensure consistency. The second intervention was similar to the first but 
included the addition of motivational enhancement. Again, this was a manualized 
approach to ensure consistency and fidelity.  As both treatments are evidence based 
an aim of the study was interested in whether alexithymia influences rates of 
abstinence. They found that there was no significant difference between alexithymia, 
intervention strategy and days abstinent (Cohen’s d= 0.03). They found that poor 
attendance was unrelated to alexithymia and was significantly related to severity of 
alcohol use. A strength of the study was that they used urine and hair analysis to test 
for abstinence as well as self-report.  However, participants attended only 50% of the 
intervention and the reasons why were not explored. Also, the participants self-
referred and received financial reward so they may not be representative of most SUD 
patients. The follow-up time after intervention was 15 weeks and this is a short-time 
period for assessment for relapse. It may be that if the follow-up period as longer 
relapse rates may have been different. Overall, the Rosenblum et al. (2005) study 
scored highly against the quality criteria, was well-designed, had a large sample size 
and a robust measure of abstinence.   
 
An early study of alexithymia and treatment outcomes was conducted by Keller et al. 
(1995). They randomized 121 people with SUD, AUD or polysubstance use into three 
treatment arms investigating CBT, pharmacotherapy and supportive clinical 
management. The study scored well for methodological design, they controlled for 
anxiety and depression and concluded that there was no significant difference in 
treatment retention (Cohen’s d= 0.01) or in abstinence rates between people with or 
without alexithymia (Cohen’s d= 0). The interventions lasted a minimum of 2 sessions 
and participants were followed up at 12 weeks. The number of intervention sessions 
was unclear as it appeared some participants received more input than others which 
makes it difficult to compare across conditions. To measure abstinence, they tested 
urine and took self-reports from participants. In terms of intervention, people with 
alexithymia had more days abstinent when they received supportive management 
which is not consistent with the other studies in this review who have identified that 
CBT based interventions produced the most days abstinent. The study did not 
investigate whether SUD, AUD or polysubstance influenced treatment outcomes or 
alexithymia scores.  
	 20	








1.Morie et al. (2015) Met DSM-IV criteria 
for SUD 




treatment, 1 month, 2 
months, 6 months  
1. TAU (methadone 
maintained) 
2. TAU + CCBT 
 
8 weeks 1 month; 2 





difference in TAS-20 
scores between 
baseline and follow-
up. High levels of 
alexithymia had no 
impact on attrition. 
Higher alexithymia 
scorers had more days 
abstinent and longer 
periods of consecutive 
abstinence in TAU + 
CCBT when 
compared to TAU 
2. Timary et al. (2008) Met DSM-IV criteria 
for AUD 
Men and women 
N = 70 
 
TAS-20 





2 weeks 2 days; 2 
weeks 
Decrease in DIF 
subscale, no change in 
DDF and EOT sub-
scales. When 
depression and 
anxiety are partialled 
out alexithymia is 
relatively stable and a 
trait in AUD. 
3.Rosenblum et al. 
(2005) 
Met DSM-IV criteria 
for SUD and AUD  
Men and women  
N = 230 
TAS-20 
Baseline  
1. Group CBT N = 114 




9 sessions  







measured so unable to 
review score changes 
High alexithymics 
responded well to 
CBT compared with 
CBT + MI and had 
more days abstinent in 
both AUD and SUD 
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4. Thorberg et al. 
(2016) 
Met DSM-IV criteria 
for AUD 
Men and women  
N = 92 
TAS-20 
Baseline, follow-up 




relatively stable and 
study concluded 
alexithymia has 
relative stability and 
is a trait in AUD. 
Study did not assess 
abstinence following 
treatment  
5. de Haan et al. (2014) Met DSM-IV criteria 
for SUD  
Men and women 







benzodiazepine and methadone 
treatment  
3 weeks  3 weeks  
(77% 
followed-up) 
High relative stability 
for total TAS-20 score 
and DDF and DIF 
subscale. EOT had 
moderate relative 
stability.  
6. de Haan et al. 
(2012a) 
Met DSM-IV criteria 
for SUD 
Men and Women  




1. Group CBT 
2. Group CBT + SDMI 
3 months 3 months 
(81.3%) 
Alexithymia scores 
change from baseline 
to post-treatment. 
High alexithymia 
patients at baseline 
scored lower at 
follow-up. The results 
also revealed 
differences in relative 
stability between all 
patients with SUD. 
Findings argue against 
alexithymia as a 
stable personality trait  
7. de Haan et al. 
(2012b) 
Met DSM-IV criteria 
for SUD 
Men and Women  
N = 187 
TAS-20  
Baseline  
1. Group CBT N  
2. Group CBT + SDMI 





measured so unable to 
review score changes. 
High alexithymia 
scores had no impact 
on abstinence or 
attrition  
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8.Kopera et al. (2014) Met DSM-IV criteria 
for AUD 
Men and women 
N = 80 
TAS-20 
Baseline  








9. Loas et al. (1997) Met DSM-III criteria 
for AUD 
Men and women 




Inpatient treatment, detox Not stated  15 months  
(100% 
followed-up) 
Higher scores on 
TAS-20 were 
correlated with 
relapse, no change in 
TAS-20 scores 
reported at follow-up  
10. Keller et al. (1995) Met DSM-III criteria 
for SUD 
Men and women 










2 session minima  3 months  
(77% follow 
up) 
High levels of 
alexithymia had no 
impact on attrition or 
abstinence.  
Alexithymics had 
longer periods of 
abstinence with 
clinical management  
11. Cleland et al. 
(2005) 
Met DSM-IV criteria 






2.Group CBT + MI 
10 weeks 15 weeks  
(78%) 
Alexithymia affects 
attrition in SUD. 
There is no significant 
difference in SUD and 
poly SUD but high 
alexithymia in SUD 
has poorer treatment 
outcomes 
12. Staciewisc et al. 
(2012) 
Met DSM-IV criteria 
for AUD 
Men and women 
N = 71 
TAS-20 
Baseline 
1. CBT + affect regulation 
2. CBT + healthy lifestyle 
information  
3 months 3 months 
(74.6%) 
High levels of 
alexithymia were 
unrelated to 
abstinence. Change in 
alexithymia scores 
after treatment not 
measured.  
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Table 2: Scored papers using Down and Black (1998) criteria  
 
 
































et al (2012) 
1. Is the 
hypothesis/aim/ob




1 1 1 1 1 1 1 1 1 1 1 1 
2. Are the main 
outcomes to be 
measured clearly 




1 1 1 1 1 1 1 1 1 1 1 1 
3. Are the 
characteristics of 
the patients 
included in the 
study clearly 
described?  
1 1 1 1 1 1 1 1 0 1 1 1 




1 0 1 1 1 1 1 1 0 1 1 1 




each group of 
subjects to be 
compared clearly 
described? 
1 0 1 2 2 1 2 2 0 2 2 2 
6. Are the main 




0 1 1 1 1 1 1 1 1 1 1 1 
7. Does the study 
provide estimates 
of the random 
variability in the 
data for the main 
outcomes? 
 
1 1 1 1 1 1 1 1 1 1 1 1 
8. Have the 
characteristics of 
patients lost to 
follow-up been 
described? 
0 0 0 1 1 1 1 1 1 0 1 1 
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9. Have actual 
probability values 
been reported  
1 0 1 1 1 1 1 1 1 0 0 0 
10. Were the 
subjects who 
were asked to 





which they were 
recruited? 
0 0 1 0 1 1 1 0 0 1 1 0 
11. Were those 
subjects who 





which they were 
recruited? 
 
0 0 1 1 1 1 0 0 0 1 0 1 
12. Were the 
places and 
facilities where 




the treatment the 
majority of AUD 
and SUD patients  
 
0 1 1 0 1 1 1 1 1 1 1 1 
13. If any of the 
results of the 
study were based 
on “data 
dredging”, was 
this made clear? 
1 1 1 1 1 1 1 1 1 1 1 1 
14. In trials and 




of follow-up of 
patients 
 
1 1 1 1 1 1 1 1 0 1 1 1 
15. Were the 
statistical tests 
used to assess the 
main outcomes 
appropriate? 





1 1 1 1 1 1 0 0 0 1 1 1 
17a Were the 
main outcome 
measures used for 
ALEXITHYMIA 





17b. Were the 
main outcome 
measures used for 




1 1 1 1 1 1 0 1 1 1 1 1 





from the same 
population?  
1 0 1 1 0 1 0 0 0 1 1 1 




the analyses from 
which the main 
findings were 
drawn?  
1 1 1 1 1 1 1 1 0 0 1 0 
20. Were losses 




0 0 0 1 1 1 1 1 1 0 1 1 
21. Did study 
report that it had 
sufficient power 









De Haan (2012b) looked at whether alexithymia, as measured by the TAS-20, affects 
abstinence after relapse prevention treatment. Alexithymia was an independent variable 
used to determine whether it affected treatment efficacy. Alexithymia was assessed at 
baseline which was defined as a period of one month of controlled abstinence. The data 
from this study was taken from a larger trial examining the efficacy of group CBT and 
group CBT with an added shared decision making intervention for AUD.  However, in 
this paper the interventions were not described and what the shared decision making 
element was not adequately explained. Participants were screened for Axis I disorders but 
only if their mental health was unstable were they excluded in the study. This means 
participants were more representative of people who usually attend addiction services. 
They measured alexithymia using the TAS-20 and found that alexithymia was unrelated 
to attrition. Around 53% of people with high levels of alexithymia were abstinent in the 
past 30 days at one-year follow-up which was not significantly different from people who 
were not alexithymic.  By comparing the groups of low alexithymics and high 
alexithymics they found there was no significant difference between them (Cohen’s d= 
0.2). The study looked at both people who misused alcohol alone and people with 
polysubstance misuse. Having alexithymia did not make a significant difference in relapse 
rates across single or polysubstance misuse. De Haan and his colleagues found that 
baseline levels of alexithymia were unrelated to abstinence at follow-up. A key strength 
of the study is that the follow-up is a year post treatment and that the authors were able to 
follow-up 93% of the cohort. Overall, despite some limitations the study scored highly 
using the quality criteria for methodological strength.  
 
Cleland et al. (2005) principal focus was to investigate the psychometric properties of the 
TAS-20 in SUD. However, they also measured whether having alexithymia had any 
bearing on abstinence after group based CBT psychoeducation relapse prevention 
treatment. Participants with SUD, AUD or both were not excluded if they have mental 
illness. Participants (n=114) were randomly assigned to a 10-week group delivered 
psychoeducational CBT and 116 participants to group delivered psychoeducational CBT 
with an additional motivational interviewing component. The data from both groups was 
pooled for the analysis looking at abstinence so the study was unable to determine whether 
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type of relapse prevention treatment influenced abstinence and attrition. They found that 
participants with higher levels of alexithymia attended fewer sessions of treatment and 
had poorer engagement as measured on the Helping Alliance Questionnaire. Correlations 
between levels of alexithymia and sessions attended showed there was a small negative 
effect size indicating that having alexithymia indicates poorer attendance in relapse 
prevention treatment (Cohen’s d= -0.2). They also found that alexithymic participants 
who misused alcohol at baseline were less likely to be abstinent at follow-up although the 
effect size was small (Cohen’s d= 0.31). However, they found there was no significant 
difference for alexithymic SUD and polysubstance users and abstinence at follow-up 
compared to non alexithymic participants (Cohen’s d = 0.02). Unlike other studies, this 
paper specifically investigated whether different types of substance misuse and 
alexithymia affected abstinence. Pooling together the participants for analysis has made 
it impossible to ascertain whether type of relapse prevention treatment mediates the 
relationship between alexithymia and attrition. This study did not report whether they had 
enough participants for power or actual probability values for their analysis.  
 
Morie et al. (2015) investigated a novel approach to relapse prevention in cocaine 
addiction and the efficacy of computer-based cognitive behavioural therapy. The data 
from the paper came from a larger study investigating the use of computerized CBT in 
addictions. There were 101 participants in the study who were maintained on methadone 
before the study began as is the usual pharmacological intervention. The study had five 
assessment points in which 73 participants were followed-up: pre, post, one month, two 
months and six months follow up and the TAS-20 was administered at each point. 
Participants were randomized while controlling for gender, severity of addiction and 
education into CCBT and treatment as usual which was mutual support groups. 
Alexithymia in this study was assessed to determine whether it affects the efficacy of the 
intervention. They found there was no relationship between alexithymia and attrition rate 
as assessed using T-tests. No significant difference was found between people with 
alexithymia and those who do not in the treatment condition. The reporting of the results 
was poor and they did not report means or standard deviations for each group. Therefore, 
interpreting the size of the effect was not possible with the data included in the paper. 
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They concluded that alexithymia did not impact negatively on abstinence after treatment 
and there was no significant difference between self-report cocaine use and urinalysis in 
alexithymics and non-alexithymics. Participants with high levels of alexithymia found the 
most benefit from CCBT and had more days abstinent in this condition. However, 
participants lost to follow-up were not described and whether participants were 
representative of the entire population was not reported.  
 
Kopera et al. (2014) looked at how relapse in AUD was related to emotional processing. 
The sample was 80 AUD participants who were inpatients in an alcohol rehabilitation 
centre. Participants completed a TAS-20 at the beginning of treatment only and 90% were 
followed up one year later and the completed the TAS-20 again and a completed a self-
report interview around whether or not they had been dirking in the last 30 days.  The 
relapse prevention treatment was a combination of both individual and group therapy over 
8 weeks in an inpatient setting. The content of the intervention was not adequately 
described. The authors report that some elements of the 12 step programme and relapse 
prevention was included but overall what treatment the participants received was unclear. 
Kopera et al. compared participants with high and low levels of alexithymia and found no 
difference between those who stayed abstinent and those who relapsed. Using T-tests to 
compare alexithymia scores on the TAS-20 between abstinent and non-abstinent 
participants they found that there was no significant difference between groups (Cohen’s 
d= 0.05). Therefore, they found that alexithymia does not affect abstinence rates in AUD 
after relapse prevention treatment. However, these findings must be treated with some 
caution. The amount of sessions and the content of the intervention was not clearly 
described and also whether each participant received the same length of treatment. The 
participants included in the study were assessed and excluded if they had any co-morbid 
Axis I diagnosis. This controlled for the confounding variables of depression and anxiety 
as Leising, Grande & Faber (2009) reported that this overinflates scores on the TAS-20. 
However, excluding participants with mental health problems is not representative of the 
usual people who present to addiction services with estimates of co-morbid Axis I 
disorders at 50-60% (Conway, Brewerton, Wilson & Hodges, 2006). Abstinence was 
measured at one year follow-up by either self-report of family report. Although there was 
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a 1 year follow-up it was only abstinence in the last 30 days that was assessed. This may 
give an unreliable picture of abstinence during the year between intervention and follow-
up. Also, it was not discussed whether participants had had other relapse prevention 
treatment in the intervening year.  
 
The final study that looked at psychosocial relapse prevention treatments was Stasiewicz 
et al. (2012) who examined alexithymia within an AUD population. They randomized 71 
participants into two groups. The first was group-based CBT with affect regulation 
strategies and the second was group-based CBT with health and lifestyle 
psychoeducation. One of the study’s key objectives was to investigate the relationship 
between alexithymia and treatment outcomes after a relapse prevention intervention. The 
authors defined attrition as not attending the 3-month follow-up appointment and 
attending less than 50% of the intervention sessions. After controlling for alcohol severity, 
anxiety and depression, they found that following logistic regression analysis there was 
no significant effect of alexithymia on attrition (Cohen’s d= 0). Therefore, they found that 
alexithymia was unrelated to treatment drop-out both during treatment and failure to 
attend follow-up. Elevated alexithymia scores were significantly associated with severity 
of alcohol dependence. However, higher scores on the TAS-20 were not significantly 
correlated with amount of alcohol consumed or number of days drinking post treatment 
(Cohen’s d-0.02). Therefore, alexithymia does not influence attrition or abstinence. The 
study scored highly against the quality criteria and although the sample size was relatively 
small their findings should be included in understanding the role of alexithymia in 
maintaining abstinence after treatment.  
 
Pharmacological Relapse Prevention Intervention  
Loas et al. (1997) examined whether alexithymia was a negative influence on abstinence 
after relapse prevention treatment. The study used participants from an inpatient 
psychiatric hospital who were undergoing treatment for alcohol dependence. They 
initially separated the 47 participants into two groups of alexithymics and non-
alexithymics based on scores on the Beth Israel Questionnaire (Sifeneos, 1973). Both 
groups then completed that TAS-20. The participants were followed up after 15 months 
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to examine whether participants with alexithymia had fewer days abstinent. The reasons 
for using two measures of alexithymia were unclear and also why both groups then 
subsequently completed the TAS-20. They used TAS-20 scores as a categorical variable 
when comparing abstinence rates rather than as a continuous variable as the other studies 
in this review have done. Parker, Keefer, Taylor & Bagby (2008) have advised to treat 
alexithymia as a continuous variable as small fluctuations in score can result in change in 
category and make it appear that change is significant when it is not. They compared the 
alexithymic and non alexithymic groups using T-tests and found that the demographics 
of the groups did not differ but that the proportion of people abstinent at follow up was 
higher in the non-alexithymic group. Unfortunately, exact p values were not reported but 
they stated that there was a significant difference between groups. When effect size was 
calculated using the data presented in the paper this was a large, adverse effect size 
(Cohens d=-1.04) indicating that people with alexithymia were significantly more likely 
to relapse than people without alexithymia.  Abstinence was decided by the participants’ 
psychiatrist and was recorded as abstinent at time of follow-up. The study did not examine 
number of days abstinent in the year since intervention and follow up but who was 
abstinent on the day of follow up. The method of assessing abstinence may not have been 
reliable and not considering the total time abstinent was a weakness in the study. The 
pharmacological relapse prevention intervention was poorly described and the sample size 
relatively small. Due to the significant limitations of the study the strength of their results 
is limited.  
 
2.6.4 Stability of alexithymia following relapse prevention treatment  
De Haan et al. (2012a) devised a methodologically rigorous study that evaluated changes 
in alexithymia in a randomized trial (previously described above in De Haan et al., 2012b) 
There were 187 participants across the groups and TAS-20 scores were taken at baseline 
and at three-month follow-up when the relapse prevention treatment was competed. Total 
TAS-20 scores were available for 140 people (75% follow-up). Total TAS-20, DDF and 
DIF scores were reduced significantly between baseline and follow-up (Cohen’s d= 0.19) 
suggesting no absolute stability of alexithymia.  The assessed relative stability by using 
correlations between total TAS-20 score from initial baseline measurement to 3 month 
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follow up. They found that scores were highly correlated with a large effect size (Cohen’s 
d= 0.82). Therefore, they concluded that alexithymia has no absolute stability in a SUD 
sample but it has relative stability. They also found that reduction in alexithymia scores 
were not related to length of treatment condition or type of intervention. Although the 
study was well-designed, the relatively short follow up time for assessing change in 
alexithymia should be considered when drawing conclusions about absolute and relative 
stability. It may be that a longer follow- up time is needed proceeding intervention to 
assess whether changes in alexithymia have a consistent course.  
 
Another study by the same group of authors looked at whether alexithymia was a state or 
trait (De Haan et al., 2014). They assessed 101 inpatients undergoing medical detox from 
SUD with the TAS-20 at baseline and three-week follow-up. Alexithymia was measured 
as a dependent variable to assess any change between pre and post intervention. Effects 
of withdrawal and Axis II disorders were controlled for. The study found that reductions 
in scores pre and post treatment meant that alexithymia is not absolutely stable and can 
change over time. They also found that scores had a strong regression to the mean i.e. low 
scores increased and high scores decreased. DeHaan et al (2014) also found relative 
stability with total TAS-20 scores. Overall, there was a small effect for change in overall 
TAS-20 scores (d=0.16). This would suggest that although the pre and post results on the 
TAS-20 are correlated with each other, suggesting relative stability, the effect size for this 
is small and conclusions drawn for this should be interpreted with caution. It should also 
be noted that participants had misused a range of different drug types and also used 
alcohol so it is difficult to determine whether change in stability could be related to type 
of substance used. They concluded that alexithymia is both a personality trait and a state 
influenced by depression and anxiety. Both studies conducted by the same research teams 
found mixed results. Although both found no absolute stability there was some 
disagreements about how much relative stability alexithymia has in SUD.  
 
Thorberg et al. (2016) looked at the absolute and relative stability in AUD after CBT as 
relapse prevention treatment. They started with a sample size of 355 however, only 92 
people completed the CBT programme. The reason for this high level of attrition was not 
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discussed but analysis showed no differences between completers and non-completers. 
The people who did complete were self-referred suggesting a high level of motivation and 
readiness to change which may not be representative of the entire population. Participants 
competed the TAS-20 at baseline and at three-month follow-up. Participants completed 8 
sessions of group CBT emphasizing relapse prevention and were abstinent throughout 
treatment. This reduced the likelihood of the psychological effects of detox inflating 
scores on measures of mood and alexithymia. They found that alexithymia did not have 
absolute stability and that there were significant differences in overall TAS-20 scores pre 
and post relapse prevention treatment (Cohens d = 1.57). However, they found that there 
were significant moderate correlations across the time points for TAS-20 total score 
(Cohen’s d = 0.5). Therefore, the study concluded that alexithymia had relative stability 
and is a trait with AUD participants. The length of follow-up was longer than some of the 
others and only one type of addiction was looked at to control for the possible differences 
in types of substance use in alexithymia score. Overall, Thorberg et al. study design was 
adequate but scored lower on the quality criteria for poor reporting of the reliability of 
their measures and failing to report if the study had sufficient power.    
 
Timary, Luts, Hers & Luminet (2008) examined the absolute and relative stability of AUD 
patients undergoing medical detox in an inpatient hospital. The 65 participants completed 
the TAS-20 at admission, day two and two-week follow-up. They reported that from the 
first time point to the third time point (2 week follow-up) there were significant changes 
in score suggesting no absolute stability. However, they reported that this was small effect 
size (Cohens d < 0.4). Therefore, after accounting for levels of depression and anxiety 
they found that overall levels of alexithymia decreased significantly pre and post relapse 
prevention treatment indicating that alexithymia does not have absolute stability. 
However, there was highly significant positive correlation between pre and post TAS-20 
scores with a large effect size (Cohens d = 0.8) suggesting relative stability.  This supports 
the view that alexithymia is a stable personality trait and not state dependent. However, 
the results should be interpreted with some caution. The sample size was relatively small 
and duration of follow-up was only two weeks. Also, there was a follow-up two days into 
medical detox and the effects of withdrawal symptoms on test scores was not considered.  
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Morie et al. (2015) study has been explained in detail above. In addition to whether 
alexithymia affects treatment they examined stability of alexithymia over time and after 
a relapse prevention intervention. At six-month follow-up 61 participants completed the 
TAS-20. They found no significant effect of time or treatment condition. They reported 
that people identified with alexithymia pre intervention still scored as having alexithymia 
post intervention. This study did not consider absolute and relative stability but just 
change in category. The study reported no significant change between pre and post scores 
(Cohen’s d = 0.03). In comparison to other studies looking at stability this study has the 
longest follow-up time and participants were methadone maintained therefore there was 
no effect of detox on scores. Also, participants included were addicted to cocaine creating 
a somewhat homogenous sample. Again, the other studies have investigated 
heterogeneous groups of substance misusers which may have influenced the conclusions 




Summary of Findings 
Eight studies were reviewed to address the question whether alexithymia influences 
outcomes in treatment seeking AUD and/or SUD after relapse prevention treatment. Six 
of the studies reported that alexithymia does not affect abstinence rates or attrition from 
treatment. The other two studies did not report this. Seven of the studies examined 
psychosocial relapse prevention treatments with all of them including some form of CBT. 
Of those studies, apart from Morie et al. (2015), the interventions were group based. Only 
Keller et al. (1995) and Rosenbum et al. (2005) used chemical testing as a measure of 
abstinence and the others relied on either self or clinician report. Kopera et al. (2014), 
Staciewicz et al. (2012) and De Haan et al. (2012b) looked at AUD populations only. 
However, there may have been polysubstance abuse within those samples that was not 
accounted for. They all reported that alexithymia was unrelated to abstinence after follow-
up. Five studies assessed alexithymia at pre and post intervention to investigate whether 
alexithymia is a stable construct within a substance abuse population. All the studies 
concluded that alexithymia has no absolute stability but the majority of the studies 
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concluded that alexithymia has relative stability in this population. However, there were 
short follow-up times between re-assessment of alexithymia in the majority of the 
reported studies. Only one study looked a pharmacological relapse prevention and the rest 
were examining levels of alexithymia after a CBT based psychoeducational intervention.  
 
The review found that psychological interventions, and in particular CBT, are effective 
for people with alexithymia and SUD and AUD as it may be that the skills learned help 
to maintain abstinence. It should be noted that the majority of the studies had short- follow 
up times of around 3 months. This has implications about relapse rate and if participants 
were followed-up over a longer period of time there may have been more incidences of 
relapse. The studies with had longer follow up times (Loas et al., 1997 and Kopera et al., 
2014) measured relapse differently. Loas et la (1997) relied on professional judgment and 
despite Kopera et al. (2014) having a year long follow up abstinence was only assessed in 
the preceding 30 days. It may be that there were other incidences of relapse that were not 
captured by assessing it in this way. However, due to the poor methodological quality of 
Loas et al. (1997) study and the small sample size in the pharmacotherapy condition in 
Keller et al. (1995) it is not possible to draw conclusions about whether alexithymia 
affects abstinence when medical management only is the relapse prevention treatment. 
Further investigation of this would be helpful to understand what, if any, role alexithymia 
has in abstinence and attrition rates. This may be particularly important as medical 
management is often first line treatment in stabilizing alcohol and drug addiction.  
 
This is also the first systematic that has looked at changes in alexithymia after relapse 
prevention treatment in AUD and SUD. Five studies were reviewed to answer the review 
question. Four of the papers examined change in alexithymia within an SUD population 
and one paper (Timary et al., 2008) examined AUD only. These studies identified that 
alexithymia did not have absolute stability in SUD and AUD and that absolute scores 
changed significantly over time. Two of the studies examined changes in alexithymia after 
medical detox and three after psychosocial relapse prevention treatment. This is important 
to be aware of as the different relapse prevention treatments may affect alexithymia. 
Timary et al. (2008) and De Haan et al. (2014) had very short follow up times and the 
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physiological effects of detox were not considered. De Haan (2012a) was the only study 
to find that alexithymia did not have absolute stability and also that it was partially state 
dependent and related to anxiety and depression. This study had the largest sample size 
and strongest methodological quality. However, a study by the same research team (De 
Haan et al., 2014) found that alexithymia had relative stability. Morie et al. (2015) did not 
differentiate between absolute and relative stability but their study appeared to report 
relative stability in cocaine dependent participants after six month follow up. The 
conclusions drawn from this review are tentative that alexithymia has no absolute stability 
but is a relatively stable trait in SUD and AUD. The conclusion drawn should be taken 
with caution due to varying follow up times, varying sample sizes between papers, varying 
methodological quality and that only one study looked at AUD.   
 
2.7.1Clinical Implications  
The conclusions from this review have implications for clinical practice. It has anecdotally 
been assumed that having a difficulty identifying emotions would have an impact on 
treatment. Alexithymia has been examined as a possible predictor of poor treatment 
outcomes in a number of psychological disorders. Recent research into whether 
alexithymia affects outcome in people with depression and anxiety found that it had a 
negative impact on people engaging in both pharmacotherapy and psychological therapy 
(Mori, Drago, Ronchi & Serretti, 2015). Terock et al. (2015) conducted a study examining 
alexithymia as a predictor of psychotherapeutic outcome. This was a large study with over 
700 participants with a range of psychological disorders. They also found that higher 
scores on the TAS-20 predicts poorer therapeutic outcome. However, the psychological 
treatments for these studies were not CBT based. It may be that people with alexithymia 
respond better to CBT based interventions than psychodynamic interventions and emotion 
focused therapies. This, in part, corresponds to the finding of this review that alexithymia 
in people with substance and alcohol addiction does not increase the rate of relapse. Most 
the studies included were CBT based. Rufer, et al. (2004) treated patients with alexithymia 
and OCD with CBT. They found that alexithymia had no impact on treatment outcomes 
and that alexithymia was also had relative stability. Again, another study with a CBT 
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based treatment found that people with alexithymia and fibromyalgia responded better to 
CBT when compared to psychoeducation (Doherty et al., 2016).  
 
Alexithymia appears to have relative stability in a substance misuse population. This fits 
with theories proposed about the development of alexithymia as a product of trauma, 
disrupted attachment and lifelong deficits in emotional regulation. Other personality 
constructs that are the result of the same experiences, such as Borderline Personality 
Disorder, are also thought to be relatively stable but can be amenable to change through 
psychological therapy (see Fonagy and Bateman, 2005 for review).  
 
Limitations 
The studies included in the review were not homogenous in design which makes 
comparisons between studies difficult. This limits the ability to draw firm conclusions 
from the synthesis of the papers included.  All studies used the TAS-20 self-report 
measure to identify alexithymia. As previously discussed this is the most widely used 
measure reported in the literature. However, there has been some debate as to whether 
self-report measures of alexithymia are accurate. Leising, Grande & Faber (2009) 
investigated whether the TAS-20 truly captured alexithymia. They found that people who 
were severely depressed had higher scores on the TAS-20 due to a negative bias in their 
recall and assessment of their abilities. It has also been proposed that people with high 
levels of alexithymia are unreliable at identifying their difficulties and are unreliable at 
completing self-report assessments (Cameron, Ogrondniczuk & Hadjupavlou, 2014; 
Taylor & Bagby, 2013). This has led to researchers proposing that alexithymia should be 
measured using a more objective scale such as the Toronto Structured Interview for 
Alexithymia or the Observer Alexithymia Scale (Bagby, Taylor, Parker & Dickens, 2006; 
Haviland, Warren & Riggs, 2000).  
 
The methodological quality of the studies varied considerably and all lacked a control 
group. There were only five studies included to answer the question whether alexithymia 
has stability after relapse prevention treatment and only one study looked at stability 
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within alcohol use disorder. Therefore, conclusions are tentative and future research 
should look at stability of alexithymia in AUD after relapse prevention treatment.  
 
2.7.2 Future Research  
Further research into the stability of alexithymia in AUD after both psychological and 
pharmacological relapse prevention treatments would add to understanding of the 
construct of alexithymia in addictions. As the majority of the studies had short follow-up 
times, it may be that further research needs to consider whether assessing alexithymia at 
longer follow-up is able to add to understanding about the stability of this construct over 
longer periods of time. A possible future direction of research could investigate whether 
changes in alexithymia are affected by the type of intervention used. The majority of the 
studies here investigated a group psycho-educational Cognitive Behavioural approach. It 
would be helpful to see if these findings are replicated when other types of psychological 
relapse prevention strategies are used such as individual CBT or motivational 
interviewing. Also, the interventions were problem focused and there is some evidence 
that people with alexithymia respond better to this type of intervention when compared to 
more emotion-focused therapies (Cameron, Ogrondniczuk & Hadjupavlou, 2014; 
Ogrodniczuk, Piper & Joyce, 2011) and this warrants further investigation within a 
substance use population. Finally, all of the studies used the Toronto Alexithymia Scale 
and relied on self-report assessment of alexithymia. Further research into observer rated 
scales and a multi-modal assessment of alexithymia would also add further understanding 
as to whether alexithymia is a personality construct in people who misuse alcohol and 
substances.  
 
2.7.3. Conclusions  
This review has been able advance previous findings from Thorberg et al. (2009) in their 
review of alexithymia and alcohol use disorders. They reported mixed findings for 
alexithymia being related to attrition rates and relapse. This review has concluded that 
most papers found there is no relationship between alexithymia, attrition rates and relapse 
in AUD and SUD. Overall, alexithymia does not influence treatment outcomes i.e. 
abstinence after relapse prevention treatment. Alexithymia also does not affect attrition 
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from treatment. Alexithymia appears to have relative stability and be a personality trait in 
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Objective: There has been much research into the prevalence of trauma within alcohol 
and substance use populations. However, it is less well known what psychological 
variables influence the relationship between trauma and addiction. To date there has been 
no studies looking at whether there are differences between experience of trauma, 
alexithymia, dissociation and emotional regulation and type of addiction. This study aims 
to investigate whether participants with poly-substance addiction will have higher 
incidents of trauma, dissociation, alexithymia and poorer emotional regulation when 
compared to alcohol and drug dependence alone.  
Method: 91 participants took part in the study and completed four self-report measures: 
Impact of Events Scale-Revised, Toronto Alexithymia Scale, Difficulties in Emotional 
Regulation Scale and the Dissociative Experiences Scale.  
Results: There were no significant differences between AUD, SUD and polysubstance 
use with regards to trauma, alexithymia and emotional regulation. Participants in the 
polysubstance group had significantly higher scores on the dissociation measure. Multiple 
regression analysis found that emotional regulation, alexithymia and dissociation could 
predict 47% of the variance of trauma when the whole dataset was pooled.  
Conclusions: It appears that what type of addiction is not important in people with trauma 
and emotional regulation problems. Emotional dysregulation, alexithymia and 
dissociation predict trauma in people with alcohol and substance use disorders. 
 
3.3 Highlights 
• No differences in trauma, emotional regulation and alexithymia between 
groups  
• Dissociation was significantly higher in the polysubstance use group 
• Multiple regression found that trauma could be predicted by emotional 
regulation, alexithymia and dissociation in a mixed alcohol and drug 
addiction population.  
 
KEYWORDS: Trauma, alexithymia, dissociation, emotional regulation, alcohol use 





Trauma and Dissociation in Addiction  
Many of the people who attend treatment for substance use disorder (SUD) and alcohol 
use disorder (AUD) have a history of trauma (Jacobsen, Southwick and Kosten, 2001). 
Some estimates put this at between 33-50% (Brady et al., 2004). Experiencing trauma can 
lead to psychological disorders, emotional dysregulation and dissociation (Read, Brown 
& Kahler, 2004). Trauma also heightens the risk of developing drug and alcohol addiction 
(Dansky et al., 1997; Deykin and Buka, 1997). Chilcoat & Menard (2003) found that 
adults diagnosed with post-traumatic stress disorder (PTSD) are five times more likely to 
misuse alcohol and drugs than those without PTSD. Driessen et al. (2008) conducted a 
multi-site study looking at prevalence rates of trauma in addiction. They found that almost 
40% of the substance users met criteria for PTSD. This was higher when compared with 
the AUD group (34%). This is significantly higher than lifetime prevalence for adults in 
the general population which is estimated to be between 3.6% and 9.7% (Kessler at al., 
2005). Given that AUD and SUD populations are likely to have high rates of trauma and 
have other significant mental health disorders (Miller, Forchimes & Zweben, 2011) it is 
important to understand the psychological variables that affect the relationship between 
trauma and addiction. 	
	
The high comorbidity of early life trauma and addiction have led researchers and 
clinicians to conceptualise addiction as an attachment disorder (see Flores, 2011). 
Attachment theory identifies different patterns of attachment which directly influence 
how people regulate emotions and cope in times of stress (Hesse, 1999). The prevalent 
theory of addiction development and maintenance is that that substance abuse is a 
“chemical dissociation” and an attempt by people to manage their emotions (Roesler & 
Dafler, 1993). There is some evidence that people with trauma histories who misuse 
alcohol and drugs do so to forget trauma memories (Somer, Altus and Ginzburg, 2010). 
De Rick et al. (2009) looked at AUD and attachment style in 101 inpatients. They found 
that most patients reported disrupted attachments and had co-morbid psychiatric 
diagnoses.  A review of attachment and addiction in adolescents also found that people 
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with addictions more often reported insecure attachment relationships when compared to 
healthy controls and this was a highly significant and large effect (Schindler et al. 2007). 	
 
Researchers found that PTSD in SUD patients most often occurs prior to development of 
addiction and that childhood abuse was the most commonly reported trauma (Brady, 
Dansky, Sonne & Saladin, 1998). Trauma, and childhood trauma has been found to be an 
important predictor of dissociation (Chu & Dill, 1990). Zlotnick et al. (1997) reported that 
dissociation is related to trauma in psychiatric patients with SUD. Studies investigating 
dissociation in substance abuse have found that it is related to addiction severity, 
suicidality and it may have a detrimental impact on treatment outcome (Karadag et al., 
2005; Evren et al., 2007). Karadag et al. (2005) found that patients with SUD who had 
comorbid problems with dissociation and trauma also used a higher number of different 
drugs. Najavits and Walsh (2012) found that people who reported higher levels of 
dissociation held the belief that their substance misuse could manage their emotional 
distress. Having poor attachment relationships  
Emotional Regulation in Addiction 
The experience of a traumatic event, especially in childhood, can lead to lifelong 
difficulties with emotional regulation and dissociation (Demers, 2015). Petit et al. (2015) 
found that emotional dysregulation may maintain AUD and SUD as it increases cravings 
for alcohol which is used as a way to manage distress. Having disrupted attachments can 
lead to maladaptive coping strategies such as poor emotional regulation (Meifen et al., 
2005). Emotional regulation refers to the inability to manage behaviour when distressed, 
a lack of understanding and awareness of one’s emotional response and a lack of helpful 
problem solving strategies to manage this distress (Aldao and Nolen-Hoeksema, 2010). 
Emotional regulation also encompasses an unwillingness to feel emotion and therefore 
people actively seek to avoid feelings (Gratz and Roemer, 2004).  Gratz and Roemer 
(2004) have identified impulse control as a behavioural component of emotional 
regulation. This may be particularly relevant to substance use populations where 
gratification seeking (drug use) occurs in the context of efforts to regulate one’s emotions 
and reduce aversive feelings (Tice et al., 2001). This has been identified as an important 
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component to address in the treatment and management of addiction (Evrenden, 1999; 
Fox et al, 2007). Several studies have found that individuals who have experienced trauma 
struggle to regulate their emotions (Tull et al, 2007; Weiss, Tull, Anestis and Gratz, 2013). 
In addition, individuals with SUD who have experienced trauma have poor emotional 
control and impaired emotional processing compared to individuals without a concurrent 
addiction (Fox, Hong & Singa, 2008; Foa and Kozak, 1988).   
One particular example of difficulties in affect regulation commonly found in SUD and 
AUD is alexithymia (Taylor, Bagby & Parker, 1997). It was first identified by Sifeneos 
(1973) as an inability to describe emotion. Taylor, Parker and Bagby (1997) have further 
defined and broadened the original concept and have identified five key deficits people 
with alexithymia display. These are: difficulty in identifying emotion, difficulty in 
expressing feelings, reduction or inability to experience emotions, difficulty in imaging 
another person’s emotions and finally, a limited capacity to fantasize or use 
representational thought (Taylor, Bagby and Luminet, 2000).  Estimates of rates of 
alexithymia in the general population range between 6% and 10% (Hintikka et al., 2001; 
Kokkonen et al., 2001).  A review of alexithymia in alcohol use disorders indicated 
prevalence rates between 45% and 67% (Thorberg et al., 2009). Individuals with SUD 
also have higher levels of alexithymia, with reported rates of 42% in one study and 50% 
in another (Haviland et al., 1994, 1988).  
 
Thorberg et al. (2011) examined attachment relationships and alexithymia in an AUD 
population and found that alexithymic people with AUD reported higher levels of 
childhood trauma and higher levels of anxious attachment that non alexithymic AUD 
participants. Alexithymia has been proposed to be a consequence of complex trauma, 
disrupted attachment and associated with dissociation (Bermond et al., 2008; Berembaum 
& James, 1994; Schafer at al., 2010). It has been proposed by Berenbaum (1996) that 
alexithymia may itself be a reaction to early trauma and functions as a coping mechanism 
to “numb” body sensations and emotions. This same “numbness” is common in 
individuals with dissociative disorders. Symptoms of dissociation resulting from trauma 
may include feelings of depersonalization and a lack of integration of thoughts, feelings 
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and experiences which can result in fragmented memories of the trauma (APA, 2000). 
Bujarski, Klanecky & McChargue (2010) found the relationship between alexithymia and 
alcohol-related risk was moderated by exposure to trauma. They also found that exposure 
to multiple traumatic events were associated with greater scores on the Toronto 
Alexithymia Scale (TAS; Parker and Bagby, 1997). It has been hypothesized that 
dissociation may be protective in cases of severe trauma (van Ijsendoorn & Schuengel, 
1996; Giesbrecht, Lynn, Lilienfeld & Meckelbach, 2008). However, in the longer term, 




To date, literature examining the relationship between PTSD, dissociation, alexithymia 
and emotional regulation in addiction is limited. It has been widely established that there 
is a link between trauma and addiction but it is less well understood what other 
psychological variables affect the relationship between the two. Some studies have 
examined combinations of these constructs but most have used an AUD population only. 
Stasiewicz et al. (2012) identified the need to understand whether severity of alexithymia 
is related to type of substance misuse. Schafer et al., (2010) conducted a large, multi-site 
study examining childhood trauma and dissociation in AUD, SUD and polysubstance 
misuse. They found that people with polysubstance misuse had higher levels of 
dissociation than the other two groups. They also found higher levels of reported 
childhood traumatic experiences in the polysubstance group when compared to alcohol 
and drug use disorders.  Craparo, Ardino, Gori and Caretti (2014) examined the 
relationships between trauma, dissociation and alexithymia in AUD. They concluded that 
these variables are predictors of alcohol addiction. Due to this previous research, it was 
decided to extend what has been previously investigated as there is no published research 
looking at whether alexithymia, emotional regulation and dissociation influence the 
relationship between PTSD and types of addiction. Understanding the nature of these 
relationships and also the prevalence of PTSD, alexithymia, dissociation and poor 
emotional regulation ability could aid assessment of the psychological difficulties of 
people who present to services with addiction issues. It has been established that poor 
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emotional regulation and attachment relationships have a detrimental effect on therapeutic 
alliance and treatment outcome (see Smith, Msetfi & Golding, 2010 for a review). 
Therefore, due to the relapsing nature of addiction it is important to understand what 
factors may negatively influence treatment outcome. The aim of the study is to explore 
the relationships between alexithymia, emotional regulation and dissociation are how they 
relate to PTSD in SUD, AUD and polysubstance use groups. Therefore, it is predicted 
that participants with poly-substance addiction will have higher incidents of trauma, 
dissociation, alexithymia and poorer emotional regulation when compared to alcohol and 




The study population was selected from people who had alcohol and drug problems who 
had attended NHS addiction services. All participants were screened at initial assessment 
for suitability for the service by the nursing team and they were identified as having SUD, 
AUD or both using ICD-10 criteria. Participants were included if they had a history of 
alcohol, drug or poly-substance abuse and were over 16 years of age. Participants were 
excluded if they had a cognitive impairment, current psychosis or had been misusing 
substances within the previous two weeks.  Participants had to be abstinent for two weeks 
prior to completing the questionnaires as it has been found that there can be people can 
confuse the effects of the substances themselves, the symptoms of withdrawal and the 
experience of dissociation (Langeland, Draijer & van der Brink, 2002). Participants had 
to be able to give their informed consent to take part in the study.  
 
In total 138 individuals were invited to take part. Of those 10 people declined with the 
most common reasons given were that they did not want to or that they did not have time. 
31 people had misused alcohol or drugs in the two weeks prior to the study and were 





Power Analysis  
A power analysis was conducted to determine the number of participants necessary for 
regression analyses. For this investigation, power was set at 0.80, alpha was set at 0.05, 
and a moderate effect size (F=0.15) (Cohen 1977) was assumed. This effect size was 
based on previous research findings that looked at differences in types of substance 
misuse, dissociation and trauma (see Schafer et al., 2010). The analysis indicated that a 
total of 117 participants, which is 39 participants for each group, were needed for this 
investigation.  
 
3.5.2 Materials   
Impact of Events Scale-Revised (Weiss and Marmar, 1997)  
The IES-R was developed to reflect the DSM-IV criteria for post-traumatic stress disorder 
(PTSD). It is a 22-item self-report measure that assesses distress caused by traumatic 
events. Items correspond to 14 of the 17 DSM-IV symptoms of PTSD. Respondents are 
asked to consider a traumatic incident they have experienced and then indicate how much 
they were distressed or bothered by it during the past week. Items are rated on a 5-point 
Likert scale ranging from 0 ("not at all") to 4 ("extremely"). The IES-R yields a total score 
and subscale scores can also be calculated for the intrusion, avoidance, and hyperarousal 
subscales. The IES-R was not developed to be diagnostic, however, cutoff scores of 
greater than 33 for a preliminary diagnosis of PTSD have been cited in the literature. For 
this sample, internal consistency was Cronbach’s alpha =0.77.  
Toronto Alexithymia Scale (TAS-20; Bagby, Taylor & Parker, 1994) 
This measure is a 20 item self-report scale. It has a five-point Likert scale and asked 
participants to rate their agreement to statements about emotion. It has 3 dimensions: 
difficulty identifying feelings (DIF), difficulty describing feelings (DDF) and externally 
oriented thinking (EOT). This measure was chosen as it has good internal consistency 
Cronbach’s alpha= 0.91 for this sample. It is the most reliable measure of alexithymia 
reported in the literature. In addition, it has been used extensively and validated for use 
within alcohol and drug addicted populations (Cleland et al, 2008).  
	 52	
Difficulties in Emotional Regulation Scale (DERS; Gratz & Roemer, 2004) 
The DERS is a 36-item self-report questionnaire designed to assess multiple aspects of 
emotion dysregulation. It is a 5-point Likert scale that asks participants to rate how often 
they thought or performed the statements. The measure produces a total score as well as 
scores on six scales: non-acceptance of emotional responses, difficulties engaging in goal 
directed behaviour, impulse control difficulties, lack of emotional awareness, limited 
access to emotion regulation strategies and lack of emotional clarity. There is no cut-off 
score for the DERS but higher scores indicate more difficulties with emotional regulation. 
The DERS displayed good internal consistency (Cronbach’s alpha = 0.93 for this sample). 
Although it has not been specifically validated in an addictions population it has been 
used extensively with people with AUD and SUD (see Azizi, Borjali & Golzari, 2010; 
Staciewicz et al., 2008).  
Dissociative Experiences Scale (DES; Bernstein and Putnam, 1986) 
The DES is used to measure dissociative symptoms. It is a 28 item self-report measure. It 
is not diagnostic and rather is a screening tool. It asks participants to rate a percentage of 
how often they have experienced the statements in the measure. An average score is then 
calculated and any score over 30% indicates problems with dissociation. It has 3 
subscales: absorption, depersonalisation and amnesia. It will be made clear to respondents 
to report only on experiences they have had while not under the influence of alcohol or 
drugs. This measure was chosen as it has well established predictive validity of 
dissociative disorders and traumatic experiences. Internal consistency for this sample was 
Cronbach’s alpha=0.82. 
3.5.3 Procedure 
Individuals attending NHS addiction services were provided with a study information 
sheet by their usual key worker who was either a nurse or psychologist. Participants were 
given information forms about the study and if they decided to take part gave their written 
consent. Almost all questionnaires were administered by the principal researcher and were 
completed in the clinic. Approximately 15% of the questionnaires were read out to 
participants for them to give their response orally. This was due to low levels of literacy 
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and people needing additional support to complete the questionnaires. All responses to 
the questionnaires and demographic information were kept anonymous and all procedures 
were approved by national and local NHS Ethics Committees. 
 
3.6 RESULTS 
3.6.1 Exploratory analysis 
Exploratory analysis was undertaken to look at data distribution by plotting histograms 
and Q-Q plots for all outcome variables. From this it was observed that the data was 
normally distributed and parametric analysis was used. Boxplots and scatterplots were 
carried out to check for outliers. Using a limit of z-score ± 3.29 no data points were found 
to be out with this (Field, 2013). Therefore, the data did not need to be trimmed or 
transformed.  
Missing Data  
One participant’s data was excluded due to non-completion of an entire questionnaire. A 
further seven people’s data was excluded as they had indicated on their questionnaire pack 
that they had misused substances in the past two weeks. Missing data for the whole sample 
was less than 1%. No questionnaire had more than the acceptable number of missing items 
as specified per the questionnaire manuals. Therefore, the missing items were prorated by 
calculating the individual means and that was used to replace missing items.  
3.6.2 Overall Sample Data  
The final sample included 115 individuals (47 male and 44 females). Participants were 
divided into three groups based on the nature of their addiction issue: alcohol misuse 
(N=40), drug misuse (N=36) and poly-substance misuse (N=39). Participants had an age 
range from 18 years to 63 years (mean=38.02, s.d.=10.11). The mean duration of time for 
addiction was 15.6 years (s.d. 9.76 years). In terms of educational experience, 61.7% of 
people had school as their highest educational attainment, 28.7% had attended college and 
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9.6% had attended university. Participants provided their postcode as a way of 
determining social deprivation. This was calculated using the Scottish Index of Multiple 
Deprivation (2016). Deprivation in a local area is calculated using several factors 
including income, employment, health, education level, housing, access to community 
services and crime rate. This gives a score from 1-5 where level 1 is the most deprived 
and level 5 is the most affluent. Analysis of postcode revealed that 88.7% of participants 
lived in the areas defined as deprived (levels 1 and 2). The rest of the participants lived in 
level 3 (8.7%) and level 4 (2.6.%).  
 
In the overall sample, 78 people (67.8%) scored over the cut-off on the Impact of Events 
Scale Revised (Weiss and Marmar, 1997) which would indicate they meet criteria for a 
diagnosis of PTSD. On the TAS-20 62 people (53.9%) were identified as having 
alexithymia and 21 (18.3%) fell within the category of possible alexithymia. The average 
score on the DERS was 108 (with the total possible score 180). The averages score on the 
DES for all participants was 27, slightly below the cut-off score of 30 indicating a 
dissociative disorder. Overall, 53 people (46.1%) scored over 30 indicating a problem 
with dissociation. In the SUD condition participants reported the drugs they were addicted 
to were heroin (56%), Valium (60%), diazepam (36%), painkillers (24%), cannabis (26%) 
and cocaine (20%). Most people in the SUD group used multiple drugs (77%). In the 
polysubstance group as well as misusing alcohol, the type of drugs misused was diazepam 
(65%), Valium (53%), heroin (47%), painkillers (33%), cannabis, (18%), ecstasy (5%) 
and LSD (4%). 
 
3.6.3 Differences Between Groups 
Demographics 
Differences between groups were tested with Chi Square and one-way ANOVA’s to 
ensure that there were no differences in demographic characteristics. Table 1 shows that 
there were no significant differences between the groups with respect to gender, 




Differences on Measures between Addiction Groups  
A one-way ANOVA was conducted to determine if severity of PTSD scores as measured 
by IES was different for SUD, AUD and polysubstance use. There were no outliers as 
assessed by boxplot; data was normally distributed for each group, as assessed by Shapiro-
Wilk test (AUD p=0.6; SUD p=0.53; poly p=0.41) and examination of Q-Q plots. There 
was homogeneity of variances, as assessed by Levene’s test of homogeneity of variances 
(p=0.87). PTSD scores were higher in the polysubstance misuse group (AUD mean 39.18 
s.d. 15.48; SUD mean 39.47 s.d. 16.6; poly 44.15 s.d. 16.35), but the differences between 
types of addiction was not statistically significant, F (2,112)1.14, p=0.34.  
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χ2 (6)= 2.43 
 
0.88 
      
*Indicates highest educational level achieved 
 
Alexithymia and type of addiction was also of interest as it was hypothesized that levels 
of alexithymia would be higher in the polysubstance group. A one-way ANOVA was 
conducted to determine if there was any significant difference between groups. Again, 
TAS-20 total scores were higher in the polysubstance misuse group (AUD mean 58.33 
s.d. 14.17; SUD mean 59.53 s.d. 14.31; poly 61.23 s.d. 15.69), but the differences between 
types of addiction was not statistically significant, F(2,112)=0.39, p=0.68.  
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Differences between total emotional regulation score and type of addiction was also 
explored. A one-way ANOVA was conducted to determine if there was any significant 
difference between groups. Again, emotional regulation scores were higher in the 
polysubstance misuse group (AUD mean 105.68 s.d. 19.92; SUD mean 105.17 s.d. 19.09; 
poly 113.26 s.d. 24.66), but the differences between types of addiction was not statistically 
significant, F(2,112)=1.73, p=0.18. 
 
Finally, difference between scores on the DES as a measure of dissociation and type of 
addiction was explored. A one-way ANOVA was conducted. Again, dissociation scores 
were higher for the polysubstance use group (AUD mean 23.95, s.d. 13.26; SUD mean 
24.19 s.d. 15.72; poly mean 32.73 s.d. 13.31). There was a significant difference found 
between groups F(2,112)=4.88, p=0.009. Tukey post hoc analysis revealed that there was 
a significant difference in DES score between polysubstance misuse and AUD (mean 
difference 10.54, 95% CI (1.3-19.77)) where p=0.021. There was also a significant 
difference between polysubstance misuse and SUD (mean difference 10.27, 95% CI 
(1.04-19.49)) where p=0.025. This is summarised in Table 2. 
 











































































3.6.4 Relationships between PTSD, alexithymia, dissociation and emotional 
regulation  
As there were no significant differences between the three addiction groups and severity 
of PTSD scores, the data from the three groups was pooled for the correlation and 
regression analyses. The correlation table for PTSD, dissociation, emotional regulation 




Table 3: Correlation Table 
	
Variables 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
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 **significant p<0.001 
	
A multiple regression was undertaken to determine if emotional regulation, alexithymia 
and dissociation could predict severity of PTSD symptoms in this population. Subscales 
and total scores of each of the measures were examined to understand the relationships 
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between the variables and PTSD symptoms. It was found that total scores on the DERS, 
DES and TAS-20 provided the most predictive value. The results of the multiple 
regression were significant, R2= 0.49 F(3,111)=35.18, p<0.001. The model predicts 49% 
of variance in PTSD symptom severity in this population. See Table 4 for summary of 
regression. The regression shows that emotional regulation does not significantly 
contribute to the overall predictive utility. Alexithymia and dissociation can significantly 
predict severity of PTSD scores in a mixed sample of people with AUD, SUD and 
polysubstance misuse. 
 
Table 4: Summary of Multiple Regression for Variables Predicting PTSD Symptom 
Severity  
 B SE B b R2 Sig. (p) 











      
Dissociation  0.594 0.09 0.53  <0.001 
    0.49  
B indicates unstandardized beta coefficient; SE B is standard error of B; b is standardised beta coefficient; 
R2, coefficient of determination for whole regression  
 
3.7 DISCUSSION 
The aim of this research was to explore whether alexithymia, emotional regulation and 
dissociation were related to trauma in SUD, AUD and polysubstance use. This study 
found that alexithymia, poor emotional regulation and dissociation was able to predict a 
significant amount of variance in PTSD in a mixed AUD, SUD and polysubstance use 
population. This means that 49% of the variance in people with PTSD seems to be 
accounted for by dissociation, alexithymia and poor emotional regulation. Based on 
previous research it was predicted that the polysubstance group would have higher rates 
of PTSD, alexithymia, dissociation and poorer emotional regulation. Although the 
average scores on all of these variables was higher for the polysubstance group, the study 
did not find evidence that there were statistically significant differences between the three 
addiction groups and experience of trauma. There was a significant difference in 
experience of dissociation between the groups with people with polysubstance misuse 
experiencing significantly more problems with dissociation. The average scores of the 
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polysubstance group was also above the DES cut-off of 30 indicating clinically significant 
issues with dissociation. The prevalence of alexithymia (58.2%) in the whole group was 
in line with previous research that looked at alexithymia in AUD with reported rates being 
between 45-67% (Thorberg et al., 2009). The average score on the DERS indicated that 
people in all three groups had difficulties with emotional regulation. This fits with 
previous research which suggests that people with AUD and SUD have poorer emotional 
control when compared to social drinkers and the general population (Fox, Hong & Sinha, 
2008; Fox et al., 2007).  
 
Trauma, Addiction and Deprivation  
Around two thirds of people (67.8%) who completed the study met criteria for PTSD 
which is higher than the average figures of 30-60% quoted in the literature (Back, 2010; 
Brady, Back & Coffey, 2004). There may be several reasons for this higher incidence. 
Firstly, along with high trauma rates, around 90% of the respondents lived in areas of high 
deprivation. Various studies have looked at the effect poverty has on mental health 
(Rehkopf & Buka, 2006; Gunnell, Peters, Kannerling & Brooks, 1995) and having poor 
mental health makes it more difficult to sustain employment (Jenkins et al., 2008). Living 
in poverty can lead to chronic conditions of high stress (Collins et al., 2010) and children 
who are born in deprivation are at greater risk of having a parent who misuses substances, 
witnessing violence, and having disrupted attachments (Evans & English, 2002). There is 
a well-defined link between children having a parent who misuses alcohol or drugs and 
then developing an addiction in adulthood (Fergusson, Boden & Horwood, 2008; Nation 
& Heflinger, 2006). Having a family history of alcoholism also predicts poor emotional 
regulation in substance users (de Haan et al., 2013). Being able to establish whether living 
in poverty is a consequence of trauma and addiction or whether addiction and trauma are 
consequences of poverty is impossible to determine in this sample. However, given the 
high rates of trauma and deprivation reported it may have been useful to examine type of 
trauma. Due to ethical considerations, participants did not disclose what traumatic event 
they were referring to when completing the IES. It may have been worthwhile to look at 
complex trauma to get more of an understanding of the type of trauma people had 
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experienced and whether this impacted their experience of addiction and emotional 
regulation.   
As well as the effects of trauma and deprivation on the development of addiction, people 
with addictions experience more stigma and social exclusion than most groups in society. 
One theory of addiction proposed over the last few years has been to view addiction not 
as a medical problem but as a consequence of social isolation. March, Oviedo-Joekes and 
Romero (2006) looked at drug addiction and social exclusion in a large study spanning 
ten European cities. They found that social exclusion exacerbates drug use and poor 
mental health. It may be that the high levels of social deprivation found in the study could 
be partly explained by the idea that social exclusion is a risk factor for development and 
maintenance of addictions.  
 
Self-Medication, Trauma and Addiction   
The findings from this study fits partially with Schafer et al. (2010) findings that high 
DES scores were prevalent in polysubstance inpatients. However, the mean scores for all 
groups in this study were higher than what they reported. Somer (2003) proposed that 
people with misuse drugs do so as a strategy to cope with painful memories and 
experiences. He suggested that when attempts at coping fail or are ineffective, other ways 
of distancing psychological distress are sought. This can result in people using alcohol 
and drugs to produce a chemical numbing and dissociation. This may be particularly 
relevant when people have poor emotional regulation skills or find recognising emotions 
problematic (Fernandez-Serrano, Loranzo, Perez-Garcia & Verdejo-Garcia, 2010). Somer 
& Avni (2003) have also proposed that when psychological dissociation is not effective 
and people need further ways of distancing themselves from the sequelae of trauma, this 
is when substance use becomes self-medication. Khantzian (1977) first proposed that 
addiction be viewed as an attempt at self-medicating around 40 years ago and a 
considerable amount of research has been conducted in that time. The original idea was 
based in psychoanalytic tradition and has sound criticism due to its proposition that 
negative affect and aggression in addiction arise from inadequate ego mechanism and that 
all people with addiction share the same personality traits (Hall & Queener, 2007).  More 
recent adaptations to the theory consider that AUD and SUD are the result of poor affect 
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regulation, low self-esteem and poor self-care (Khantzian, 1990). However, despite the 
limitations of the theory clinical observations have noted that one of the reasons given for 
AUD and SUD is to relieve negative feelings (Weiss, Griffin & Mirin, 1992; Voruganti, 
Heslegrave & Awad, 1997). The high co-morbidity of mental health problems and 
addiction is also proposed as evidence for the self-medication theory. In the current study 
this may be a factor in accounting for the high levels of trauma, emotional dysregulation 
and dissociation found. 
 
3.7.1 Limitations 
Self-report was relied on for not only the measures chosen but for whether participants 
had misused alcohol or drugs in the two weeks prior to completing the questionnaires. It 
would have been more reliable to use chemical testing such as urine analysis to ensure 
that the scores on the measures were not the result or intoxication or withdrawal. 
However, it was out with the scope of the study to be able to do that.  
 
There was no measure of addiction severity included in the study which means that 
severity and how it relates to type of addiction, trauma, emotional regulation, alexithymia 
and dissociation was not assessed. There was also no assessment of other mental health 
problems, in particular, anxiety and depression. Previous research has found that anxiety 
and depression can affect scores on the TAS-20 (Marchesi, Ossola, Tonna & De Panfilis, 
2014). If this research was to be replicated a measure of severity and also depression and 
anxiety should be included.  
 
Future studies should aim to develop the current finding as it was found that emotional 
regulation, alexithymia and dissociation all had important relationships with PTSD and 
addiction. Research should extend to looking at whether investigating chronic and 
complex PTSD in this population add to our understanding of the relationship between 
the investigated variables and severity of addiction. The variables investigated are 
common symptoms in complex PTSD (Herman, 1992; Ford et la., 2007). Therefore, it 
would be informative to understand whether emotional regulation, alexithymia and 
dissociation mediate the relationships between complex PTSD and addiction.  
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3.7.2 Conclusions  
Overall, the study did not find any differences between AUD, SUD and polysubstance 
misuse and experiences of trauma. There were also no differences between groups in 
prevalence of alexithymia or emotional regulation. The study did find that the 
polysubstance group had significantly higher level of dissociation that the other two 
groups. Overall, the sample had a high proportion of trauma at 67.8% and this was slightly 
higher than has been reported in the literature. Multiple regression analysis found that 
emotional regulation, alexithymia and dissociation could predict 49% of the variance of 
trauma when the whole dataset was pooled. This has added to understanding about the 
relationships between poor emotional regulation, alexithymia and dissociation commonly 
co-occur with PTSD so it may be important for clinicians to understand this and to 
routinely screen for these difficulties when treating people with PTSD who have co-
morbid addictions.  The study also found that levels of deprivation as measured on the 
SIMD were also high with around 90% of respondents reported living in areas of high 
deprivation. Therefore, clinicians must have an understanding not only of the 
psychological difficulties people with addictions face but the socio-economic problems 
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obligated under this agreement to report to the NHS Lanarkshire Data Protection Office and the 
Research & Development Office infringements, either by accident or otherwise, which 
constitutes a breach of confidentiality.  
• Clinical trial agreements (if applicable), or any other agreements in relation to the study have been 
signed off by all relevant signatories.  
• You must contact the Lead Nation Coordinating Centre if/when the project is subject to any minor or 
substantial amendments so that these can be appropriately assessed, and approved, where 
necessary.  
• You notify the R&D Department if any additional researchers become involved in the project within 
NHS Lanarkshire  
• You notify the R&D Department when you have completed your research ,or if you decide to terminate 
it prematurely.  
• You must send brief annual reports followed by a final report and summary to the R&D office in hard 
copy and electronic formats as well as any publications.  
• If the research involves any investigators who are not employed by NHS Lanarkshire ,but who will be 
dealing with NHS Lanarkshire patients, there may be a requirement for an SCRO check and 
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occupational health assessment. If this is the case then please contact the R&D Department to 
make arrangements for this to be undertaken and an honorary contract issued.  
• I trust these conditions are acceptable to you. Yours sincerely, Raymond Hamill – Corporate R&D 






CONTACT ADDRESS  ROLE  
Ms Claire Stark  Trainee Clinical Psychologist  Claire.Stark@nhs.net  Principal Investigator  
Jo-Anne 
























5.3 APPENDIX C: Author Guidelines for Empirical Paper and Systematic Review  
 
Drug and Alcohol Dependence  
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Drug and Alcohol Dependence is an international journal devoted to publishing 
original research, scholarly reviews, commentaries, and policy analyses in the area 
of drug, alcohol and tobacco use and dependence. Articles range from studies of 
the chemistry of substances of abuse, their actions at molecular and cellular sites, 
in vitro and in vivo investigations of their biochemical, pharmacological and 
behavioural actions, laboratory-based and clinical research in humans, substance 
abuse treatment and prevention research, and studies employing methods from 
epidemiology, sociology, and economics.  
The rationale for this extensive coverage is the conviction that drug, alcohol and 
tobacco use/ dependence cannot be understood in their entirety from a single 
perspective and that without an understanding of other areas of research, studies by 
individual investigators may be limited. The goal of the journal is to provide 
researchers, clinicians, and policy makers access to material from all perspectives in 
a single journal in a format that is understandable and which has received rigorous 
editorial review. The hope of its editors is to promote mutual understanding of the 
many facets of drug abuse to the benefit of all investigators involved in drug and 
alcohol research, and to facilitate the transfer of scientific findings to successful 
treatment and prevention practices.  
Types of paper  
1) Full-length Reports reporting original results of research within the field of 
drug, alcohol and tobacco use and dependence. A Full-length Report typically should 
not exceed 4500 words (for the introduction, methods, results and discussion).  
2) Review Articles of specialized topics within the scope of the journal. Typically, 
these are critical reviews of a field of research. A Review Article typically should not 
exceed 6000 words for the main body of the paper (i.e., excluding references, 
tables and figures). Review Articles that will be substantially longer than 6000 
words should be discussed with the Editor-in-Chief prior to submission.  
3) Short Communications reporting on research that has progressed to the stage 
where a preliminary publication is appropriate. The maximum length is 2000 words 
plus references and illustrations. There should be not more than 2 illustrations 
(figure or tables).  
4) Commentaries express points of view on scientific matters or published papers. 
Typically, commentaries are solicited by the editors, but authors who wish to submit 
commentaries should contact the Editor-in-Chief to discuss the suitability of the 
proposed paper. A Commentary typically should not exceed 2000 words.  
5) Registered Reports (click here for more details). These submissions undergo a 
two-phase review process in which study rationale and methodology are considered 
prior to the research being undertaken.  
6) Other forms of papers. The journal does not publish letters to the editor, 
individual case studies or book reviews.  
References  
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There are no strict requirements on reference formatting at submission. References 
can be in any style or format as long as the style is consistent. Where applicable, 
author(s) name(s), journal title/book title, chapter title/article title, year of 
publication, volume number/book chapter and the pagination must be present. Use 
of DOI is highly encouraged. The reference style used by the journal will be applied 
to the accepted article by Elsevier at the proof stage. Note that missing data will be 
highlighted at proof stage for the author to correct.  
Formatting requirements  
There are no strict formatting requirements but all manuscripts must contain the 
essential elements needed to convey your manuscript, for example Abstract, 
Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and 
Tables with Captions.If your article includes any Videos and/or other Supplementary 
material, this should be included in your initial submission for peer review purposes.  
Divide the article into clearly defined sections.  
Figures and tables embedded in text  
Please ensure the figures and the tables included in the single file are placed next to 
the relevant text in the manuscript, rather than at the bottom or the top of the file. 
The corresponding caption should be placed directly below the figure or table.  
Divide your article into clearly defined and numbered sections. Subsections should be 
numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section 
numbering). Use this numbering also for internal cross-referencing: do not just refer 
to 'the text'. Any subsection may be given a brief heading. Each heading should 
appear on its own separate line.  
Introduction State the objectives of the work and provide an adequate background, 
avoiding a detailed literature survey or a summary of the results.  
Material and methods Provide sufficient detail to allow the work to be reproduced. 
Methods already published should be indicated by a reference: only relevant 
modifications should be described.  
Theory/calculation A Theory section should extend, not repeat, the background to the 
article already dealt with in the Introduction and lay the foundation for further work. 
In contrast, a Calculation section represents a practical development from a 
theoretical basis.  
Results Results should be clear and concise.  
Discussion This should explore the significance of the results of the work, not repeat 
them. A combined Results and Discussion section is often appropriate. Avoid 
extensive citations and discussion of published literature.  
Conclusions The main conclusions of the study may be presented in a short 
Conclusions section, which may stand alone or form a subsection of a Discussion or 
Results and Discussion section.  
Appendices If there is more than one appendix, they should be identified as A, B, etc. 
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Formulae and equations in appendices should be given separate numbering: Eq. 
(A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for 
tables and figures: Table A.1; Fig. A.1, etc.  
Essential title page information  
• Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible.• Author names and 
affiliations. Please clearly indicate the given name(s) and family name(s) of each 
author and check that all names are accurately spelled. Present the authors' affiliation 
addresses (where the actual work was done) below the names. Indicate all affiliations 
with a lower- case superscript letter immediately after the author's name and in front 
of the appropriate address. Provide the full postal address of each affiliation, including 
the country name and, if available, the e-mail address of each author.  
• Corresponding author. Clearly indicate who will handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that the e-mail 
address is given and that contact details are kept up to date by the 
corresponding author.• Present/permanent address. If an author has moved 
since the work described in the article was done, or was visiting at the time, a 'Present 
address' (or 'Permanent address') may be indicated as a footnote to that author's 
name. The address at which the author actually did the work must be retained as the 
main, affiliation address. Superscript Arabic numerals are used for such footnotes.  
Abstract A concise and factual abstract is required. The abstract should state briefly 
the purpose of the research, the principal results and major conclusions. An abstract 
is often presented separately from the article, so it must be able to stand alone. For 
this reason, References should be avoided, but if essential, then cite the author(s) 
and year(s). Also, non-standard or uncommon abbreviations should be avoided, but 
if essential they must be defined at their first mention in the abstract itself.  
Highlights Highlights are mandatory for this journal. They consist of a short collection 
of bullet points that convey the core findings of the article and should be submitted 
in a separate editable file in the online submission system. Please use 'Highlights' in 
the file name and include 3 to 5 bullet points (maximum 85 characters, including 
spaces, per bullet point). You can view example Highlights on our information site.  
Keywords Immediately after the abstract, provide a maximum of 6 keywords, using 
American spelling and avoiding general and plural terms and multiple concepts 
(avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations 
firmly established in the field may be eligible. These keywords will be used for 
indexing purposes.  
Abbreviations Define abbreviations that are not standard in this field in a footnote to 
be placed on the first page of the article. Such abbreviations that are unavoidable in 
the abstract must be defined at their first mention there, as well as in the footnote. 
Ensure consistency of abbreviations throughout the article.  
Acknowledgements Collate acknowledgements in a separate section at the end of the 
article before the references and do not, therefore, include them on the title page, as 
a footnote to the title or otherwise. List here those individuals who provided help 
during the research (e.g., providing language help, writing assistance or proof reading 
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Participant Information Sheet  
 
Trauma, emotional awareness, dissociation and emotional regulation in Addiction  
You are being invited to take part in a research study.  Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully. Talk to others about the study if you 
wish.  Contact us if there is anything that is not clear or if you would like more information.  Take 







































The information we get from this study may help us improve the health care services and future 
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 treatment of patients with addiction issues. 
 

































All research in the NHS is looked at by an independent group of people, called a Research Ethics 




If you have any further questions about the study please contact  
	
																			Claire	Stark	 	 	 	 	 Dr	Caroline	Sneddon	 	 	
																				Trainee	Clinical	Psychologist	 	 	 Clinical	Psychologist	
																				Addiction	Psychology	Service	 	 	 PTT	Rutherglen/	Cambuslang	
																			Douglas	Street	Clinic,	Hamilton	 	 	 Eastvale	Resource	Centre	
																				ML3	0BP		 	 	 	 														130	Stonelaw	Road,	Glasgow	









































5.5 APPENDIX E: Participant Consent Form  
	
                                                                                                        
 
 
Trauma,  emotional awareness, dissociation and emotional regulation in addiction	
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5.6 APPENDIX F:  Initial Study Protocol from IRAS  
	
DesignThe study will be a cross-sectional, quantitative design. Participants will 
complete 4 self-report measures, a demographic questionnaire which will ask for 
information including age, gender and a brief questionnaire on the duration and type of 
substance misuse.  
SampleParticipants will be recruited from NHS addiction services. Participants will be 
	 90	
existing users of NHS services and will be asked to participate by their addiction worker. 
Informed consent will be sought and the procedure explained fully.  
Sample size guidelines for multinomial logistic regression indicate a minimum of 10 cases 
per independent variable (Schwab, 2002). Previous research with people with substance 
misuse disorder and trauma symptoms have found a medium effect size. Assuming a 
power level of 0.8 with significance at p≤0.05 for the multinomial logistic regression then 
117 participants will be required for the current study. G-power was used for all 
calculations (Faul, Erdfelder, Buchner & Lang, 2009). There will be three groups: alcohol 
dependent participants, drug dependent participants and participants addicted to alcohol 
and drugs. Therefore, there will need to be a minimum of 39 participants in each group.  
ProcedureThe addiction teams in each locality will be given information about the study 
and also information leaflets. These will be given to potential participants and they can 
then opt to take part in the study. It is anticipated that the participants’ addiction worker 
will give him or her the questionnaire to complete after they have understood and 
consented to take part. Participants will be advised that they can withdraw from the study 
at any time and the individual responses will be anonymous. Participants will be asked to 
be as honest as possible and assured that their responses are confidential. Participants will 
complete the self-report measures and a demographic sheet which will ask for information 
including age, gender, postcode and length and type of substance misuse. The postcode 
will be asked as this will be used to understand the Scottish Index of Multiple Deprivation.  
It has been found that there can be some confusion between the effects of the substances 
themselves, the symptoms of withdrawal and dissociation (Langeland, Draijer & van der 
Brink, 2002). Therefore when trying to measure dissociation it is important that people 
are at least two weeks free of any substance misuse. Therefore, participants will be asked 
whether they have been abstinent for the past 2 weeks.  
Questionnaires will have addressed envelopes that participants can post back or they can 
hand them back to their addiction worker. The participants will also be asked to provide 
an email address if they wish to be contacted about the results of the study. This will be 
entirely optional and email addresses will be on a separate sheet that will not be used to 
identify the data in any way. If any participant required further information then the 
contact details of the researcher will be provided to them in the information sheet.  
Response Rates This project is being supported by NHS Lanarkshire Addictions service. 
Lanarkshire is split into two different council areas and the addictions service work 
differently in each locality. Therefore, each individual locality will be given information 
about the study. Between January and March 2015 the South Lanarkshire team received 
389 referrals for drug misuse and 820 referrals for alcohol misuse. The North Locality has 
comparable referral rates. Taking into account the 40% non-attendance for first 
appointment this gives a sizeable population of 863 participants in a 3 month period in 
South Lanarkshire alone to recruit from. It is anticipated that the needed sample size for 
this study will be able to be achieved.  
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